Factor VII gene therapy (SanaGen)

N/A

Report date: 2025/01/26 18:04:47

Base Information

Drug NameFactor VII gene therapy (SanaGen)
Drug Alias Nameadeno-associated virus-based factor VII gene therapy (SanaGen)
ClassificationBiologics
Mechanisms of ActionCoagulation factor VII stimulants
TargetsCoagulation factor VII
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSanaGen BV
China Registration ClassN/A

Develop Information

Active CompaniesSanaGen BV
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A